Skip to main content

ADVERTISEMENT

Noncolorectal

Debates and Roundtables
11/13/2019
Eileen O’Reilly, MD; Talia Golan, MD; Pascal Hammel, MD; and Teresa Macarulla, MD, PhD, discuss the findings of the POLO clinical trial.
Eileen O’Reilly, MD; Talia Golan, MD; Pascal Hammel, MD; and Teresa Macarulla, MD, PhD, discuss the findings of the POLO clinical trial.
Eileen O’Reilly, MD; Talia...
11/13/2019
Oncology
Videos
09/14/2019
Eileen O'Reilly, MD, debates in favor of using PARP inhibitors as maintenance therapy for BRCA mutation–positive pancreatic cancer.
Eileen O'Reilly, MD, debates in favor of using PARP inhibitors as maintenance therapy for BRCA mutation–positive pancreatic cancer.
Eileen O'Reilly, MD, debates in...
09/14/2019
Oncology
Videos
09/14/2019
Robert G. Maki, MD, PhD, provides an update on the new treatment options available for GISTs.
Robert G. Maki, MD, PhD, provides an update on the new treatment options available for GISTs.
Robert G. Maki, MD, PhD,...
09/14/2019
Oncology
Debates and Roundtables
08/13/2019
Ghassan Abou-Alfa, MD; Arndt Vogel, MD, PhD; and Chris Verslype, MD, PhD, FACP, discuss the significance of the REACH and REACH-2 trials.
Ghassan Abou-Alfa, MD; Arndt Vogel, MD, PhD; and Chris Verslype, MD, PhD, FACP, discuss the significance of the REACH and REACH-2 trials.
Ghassan Abou-Alfa, MD; Arndt...
08/13/2019
Oncology
Videos
07/25/2019
Andrea Sartore Bianchi, MD, discusses the HER2 Pathway in gastrointestinal cancer at the 2019 ESMO World Congress on Gastrointestinal Cancer.
Andrea Sartore Bianchi, MD, discusses the HER2 Pathway in gastrointestinal cancer at the 2019 ESMO World Congress on Gastrointestinal Cancer.
Andrea Sartore Bianchi, MD,...
07/25/2019
Oncology
Videos
07/06/2019
Rachel Riechelmann, MD, PhD, gives an update on what's new in gastrointestinal and pancreatic NETs in the past year.
Rachel Riechelmann, MD, PhD, gives an update on what's new in gastrointestinal and pancreatic NETs in the past year.
Rachel Riechelmann, MD, PhD,...
07/06/2019
Oncology
Videos
07/06/2019
David H. Ilson, MD, PhD, explains why radiotherapy should be included as part of adjuvant therapy for gastric cancer at the ESMO 21st World Congress on Gastrointestinal Cancer.
David H. Ilson, MD, PhD, explains why radiotherapy should be included as part of adjuvant therapy for gastric cancer at the ESMO 21st World Congress on Gastrointestinal Cancer.
David H. Ilson, MD, PhD,...
07/06/2019
Oncology
Videos
07/06/2019
Andrés Cervantes, MD, PhD, discusses new therapeutic agents for advanced gastric cancer at the ESMO 21st World Congress on Gastrointestinal Cancer.
Andrés Cervantes, MD, PhD, discusses new therapeutic agents for advanced gastric cancer at the ESMO 21st World Congress on Gastrointestinal Cancer.
Andrés Cervantes, MD, PhD,...
07/06/2019
Oncology
07/05/2019
NAPOX appears to be manageable, with promising antitumor activity for the first-line treatment of metastatic pancreatic cancer.
NAPOX appears to be manageable, with promising antitumor activity for the first-line treatment of metastatic pancreatic cancer.
NAPOX appears to be manageable,...
07/05/2019
Oncology
07/05/2019
Ramucirumab improves survival for patients with advanced HCC and elevated AFP regardless of prior TACE treatment, according to a post-hoc analysis of REACH/REACH-2.
Ramucirumab improves survival for patients with advanced HCC and elevated AFP regardless of prior TACE treatment, according to a post-hoc analysis of REACH/REACH-2.
Ramucirumab improves survival...
07/05/2019
Oncology